Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.62, $0.07 worse than the analyst estimate of $1.69. Revenue for the quarter came in at $6.96 billion versus the consensus estimate of $6.84 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2023 EPS of $8.65-$8.85, versus the consensus of $8.45.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.